Using in vitro engineered and transcribed reovirus m1 and s2 ssRNAs, we demonstrate that the nucleotides used to identify these ssRNAs are localized to the 5′ and not the 3′ termini. To demonstrate this, we used our previously reported S2-CAT reovirus and we report the creation of an engineered M1-CAT reovirus. The M1 gene of this virus retains 124 nucleotides from the wild type M1 gene preceding the CAT gene and 172 nucleotides from the wild type gene following the CAT gene. The engineered M1-CAT ssRNA is 1048 nucleotides in length, much shorter than the wild type M1 at 2304 nucleotides. We have used a set of chimeric s2.m1 ssRNAs to localize the packaging signals within these RNAs. By packaging signals we mean that the presence of these signals in engineered ssRNAs results in these ssRNAs being replicated to dsRNA and packaged into progeny virus. An engineered ssRNA with a 5′ sequence identical with the wild type s2 ssRNA, supported by a 3′ sequence from either the m1 or s2 ssRNA, is incorporated into a virus as an S2 dsRNA. Likewise, an ssRNA with an m1 5′ end is incorporated as an M1 dsRNA.
Introduction
The Reoviridae family has proven to be resistant to reverse genetics. The family contains more than 75 member species all with genomes containing 10, 11 or 12 dsRNA segments (Patton and Spencer, 2000; Ramig and Ward, 1991; Spence et al., 1984; Urbano and Urbano, 1994) . This is a diverse family with 4 genera infecting humans and the remaining 9, including a proposed genus of insect reoviruses and several unassigned members, infecting plants, insects, and fish. A reverse genetics system has only been developed for two members, reovirus (Roner et al., 2004; Roner and Joklik, 2001; Roner and Roehr, 2006) and recently rotavirus (Komoto et al., 2006) . Work with reovirus, 10 genome segments (Antczak and Joklik, 1992) , and rotavirus, 11 genome segments (Silvestri et al., 2004) suggests that dsRNA formation is coordinated with packaging the viral ssRNAs. These studies suggest that replication intermediates are formed that contain the "packaged set" of ssRNAs, and when the process is completed, all the ssRNAs are immediately replicated to dsRNA. This infers the ssRNAs contain the cis-acting packaging signals as opposed to the dsRNA genome segments. Our work with the reovirus s2 and m1 ssRNAs supports these observations (Roner et al., 2004; Roner and Roehr, 2006) . We have previously localized the minimal sequences within the s2 ssRNA and now present our findings for the m1 ssRNA and two chimeric s2.m1 ssRNAs. We demonstrate that the nucleotides used to identify the chimeric ssRNAs are localized to the 5′ and not the 3′ termini of the ssRNAs.
Results

Generation of an M1-CAT reovirus and identification of minimal flanking sequences
Using the cDNA template pM1CAT1330 (Fig. 1) , we have transcribed an ssRNA and successfully incorporated it into a stable reovirus (Fig. 1) . The M1CAT viruses represent approximately 10% of the viruses generated following lipofection of the M1CAT ssRNA together with a set of nine wild type (wt) serotype three, strain Dearing (ST3D) ssRNAs. The remaining 90% contain the wt ST3D M1 gene. The source of the wt M1 gene is the m1 ssRNA not removed following cleavage treatment with the M1 antisense oligo and RNase H treatment. The yield of S2CAT virus using this procedure has always been approximately 15%. Reasons for this difference are addressed in the discussion. The m1 ssRNA produced from the cDNA template is 1330 bp in length. As shown in the autoradiogram in Fig. 1 , when this ssRNA is replicated to dsRNA and incorporated into a virus, it has a migration rate similar to the ST3D S1 dsRNA which is much larger at 1416 bp. Sequencing the M1-CAT1330 dsRNA confirms that the RNA is as engineered with a length of 1330 bp. The explanation for this anomaly is that the secondary structure of dsRNAs in SDS-PAGE gels has a significant impact on their migration rates (Clarke and McCrae, 1982; Roner and Joklik, 2001) .
Using the methods we described for the s2 ssRNA (Roner et al., 2004; Roner and Roehr, 2006) , we have used the cDNA pM1CAT1330 to find the minimal 5′ and 3′ flanking sequences required for the m1 ssRNA to be incorporated into a reovirus. We were able to reduce the total length of the m1-CAT ssRNA from 1330 to 1048 nucleotides and produce a reovirus containing this short m1 ssRNA. In Fig. 1 , the genome segments of this virus (ST3D with M1-CAT 1048) are shown. This virus was produced by reducing the 5′ M1 nucleotides of pM1CAT1330 from 343 to 124, and the 3′ nucleotide length from 235 to 172 nucleotides. This ssRNA when replicated to dsRNA and incorporated into a virus migrates much closer to its actual size than the 1330 dsRNA, when compared to the known sizes of the remaining ST3D dsRNA segments. Again, sequencing of this dsRNA confirms its engineered sequence and length. To discover the 5′ minimum of 124 and the 3′ minimum of 172, we initially made large deletions of these regions followed by individual nucleotide deletions, as we reported for the s2 ssRNA (Roner et al., 2004; Roner and Roehr, 2006) . These deletions are summarized in Table 1 and the in vivo activity of the created ssRNAs is shown in Fig. 2 .
Activity of chimeric ssRNAs using single gene knock-out acceptor RNA sets
Two chimeric ssRNAs were created using the minimum 5′ and 3′ sequences identified for the s2 and m1 ssRNAs. The ssRNAs contained 5′ and 3′ sequences from either the s2 or m1 ssRNAs, flanking the CAT gene. The chimeric ssRNAs 5′ S2-CAT-M1 3′ and 5′ M1-CAT-S2 3′ are only slightly different in length than the starting ssRNAs 5′ S2-CAT-S2 3′ , from plasmid pS2CAT3 m (Roner and Roehr, 2006) , and 5′ M1-CAT-M1 3′ , from plasmid pM1CAT1048. Outlined in Fig. 3 is a summary of the lipofection procedure, an SDS-PAGE gel showing the dsRNA genome segments of the chimeric viruses and a table summarizing the structure of the ssRNAs. Fig. 4 summarizes the activity of these ssRNAs when lipofected into cells to produce recombinant viruses.
Individually the two chimeric ssRNAs were tested for activity using single knock-out sets of 9 ssRNAs created by removing either the s2 or m1 ssRNA as described. The ssRNA sets were then lipofected into the cell line providing the protein coded for by the deleted gene and any virus produced during the next 48 h screened for on the same cell line. Multiple samples were harvested for screening, for analysis to confirm the presence of the lipofected CAT ssRNA and to detect any CAT dsRNA that was produced. In Fig. 4A , the first two ssRNAs are the controls previously described, pS2CAT3 m listed as 5′ S2-CAT-S2 3′ to highlight the source of the 5′ and 3′ sequences, and pM1CAT1048 listed as 5′ M1-CAT-M1 3′ to again highlight the source of the 5′ and 3′ sequences. The third, fourth and fifth ssRNAs 5′ S2-CAT-M1 3′ contain the minimum s2 5′ region and the minimum m1 3′ region flanking the CAT sequence. This ssRNA was tested using three core RNA sets, for the ability to be incorporated as an s2 or m1 ssRNA, or both. We found that the chimeric ssRNA 5′ S2-CAT-M1 3 was incorporated into an infectious reovirus in place of the S2 dsRNA, but never in place of the M1 dsRNA, Fig. 4A , RNAs 3 and 4. The sixth, seventh and eighth ssRNAs 5′ M1-CAT-S2 3′ contain the minimum m1 5′ region and the minimum s2 3′ region flanking the CAT sequence. This ssRNA was tested using three core RNA sets, for the ability to be incorporated as an m1 or s2 ssRNA, or both. We found the chimeric ssRNA 5′ M1-CAT-S2 3′ was incorporated into an infectious reovirus in place of the M1 dsRNA, but never in place of the S2 dsRNA, Fig. 4A , RNAs 6 and 7. The activity of these ssRNAs when added to sets of 8 ssRNAs is presented next, Fig. 4A , RNAs 5 and 8.
Activity of chimeric ssRNAs using double gene knock-out acceptor RNA sets Using a dual-knock-out set of eight ssRNAs, we examined the capacity of individual ssRNAs to replace both the wt s2 and m1 ssRNAs. The capacity of the chimeric ssRNAs 5′ S2-CAT-M1 3 or 5′ M1-CAT-S2 3′ to individually replace both the s2 and m1 ssRNAs was tested, Fig. 4A , RNAs 5 and 8. In these experiments, neither chimeric ssRNA was ever incorporated into an infectious reovirus in place of both the S2 and M1 dsRNAs. Even though the chimeric ssRNAs were never replicated to dsRNA or incorporated into virus, they were stable and readily detected within the lipofected cells, suggesting that degradation was not the reason for inactivity, Fig. 4B . We then examined the capacity of the chimeric ssRNAs 5′ S2-CAT-M1 3 and 5′ M1-CAT-S2 3′ together to replace both the s2 and m1 ssRNAs in an individual virus, Fig. 4A , RNAs 9 and 10. Together the ssRNAs and double knock-out acceptor RNAs were lipofected into the cell line providing both the σ2 and μ2 proteins and any virus produced during the next 48 h screened for on the same cell line. Multiple samples were harvested for screening, for analysis to confirm the presence of the lipofected CAT ssRNA, and to detect any CAT dsRNA that was produced. We found that the 5′ S2-CAT-S2 3′ ssRNA could replace the wt s2 and the 5′ M1-CAT-M1 3′ ssRNA could replace the wt m1 and both be replicated to dsRNA yielding a stable virus with both an S2-CAT and M1-CAT gene, Fig. 4A , RNA 9, and Fig. 3B . When both chimeric ssRNAs were combined with a set of eight ssRNAs missing both the s2 and m1 ssRNAs, these chimeric ssRNAs were detectable, replicated to dsRNA and incorporated into virus in place of the deleted s2 and m1 ssRNAs, Fig. 4A , RNA 10, and Fig. 3B . The S2 dsRNA was always 5′ S2-CAT-M1 3 and the M1 dsRNA always 5′ M1-CAT-S2 3′ .
Discussion
This work summarizes our expansion of the reovirus genetics system to include the M1 gene and chimeric s2.m1 ssRNAs. The M1-CAT virus is 10% of total virus generated while S2-CAT is 15% of total. The primary reason for this difference in efficiency is that we found removal of the wt ST3D m1 ssRNA using an oligo and RNase H to be less efficient than removal of s2 ssRNA using the same method. This is likely due to intrinsic properties of the oligo selected, and possibly the m1 ssRNA secondary structure at or near the oligo binding site. As for the oligo used to remove the s2 ssRNA, the oligo selected for the m1 was based on efficient cleavage of the wt m1 ssRNA and minimal cleavage of the remaining 9 ssRNAs. The efficiency in generating an M1-CAT reovirus was still high enough to allow isolation of all the engineered viruses.
The engineered M1-CAT ssRNA is 1048 nucleotides in length, much shorter than the wild type m1 at 2304 nucleotides. The M1 gene of the virus generated from this ssRNA retains 124 nucleotides from the wild type M1 gene preceding the CAT gene and 172 nucleotides from the wild type gene following the CAT gene. The minimal m1 sequences flanking the CAT gene required by the ssRNA to be recognized as a reovirus m1 ssRNA, replicated to a dsRNA and incorporated into a progeny virus as an M1 genome segment, are greater than those required by the s2-CAT ssRNA. For the m1-CAT ssRNA 5′, 124 nucleotides versus 96 for the s2, and for the m1 3′ 172 nucleotides versus 98 for the s2. We are working on the l1 ssRNA and will know soon if the correlation between genome length and increasing length for the required 5′ and 3′ sequences seen from the s2 to the m1 extends to the larger reovirus genes.
We have used a set of chimeric s2.m1 ssRNAs to localize the packaging signals within these RNAs. Using in vitro engineered and transcribed reovirus m1 and s2 ssRNAs, we demonstrated that the nucleotides used to identify these ssRNAs are localized to the 5′ and not the 3′ termini. An engineered ssRNA with a 5′ sequence identical with the wild type s2 ssRNA, supported by a 3′ sequence from either the m1 or s2 ssRNA, is incorporated into a virus as an S2 dsRNA. Likewise, an ssRNA with an m1 5′ end is incorporated as an M1 dsRNA.
We have spent a notable amount of time examining RNA secondary structures predicted to be present in the required 5′ and 3′ regions of the s2 and m1 ssRNAs for conserved structures. To date we have found only the previously discussed structure, involving a loop containing a free A-U-U, predicted to be present in the 5′ ends of all ten reovirus ssRNAs (Roner et al., 2004) . We know that the s2 ssRNA contains an AUU sequence involved in a predicted secondary structure that if mutated prevents the RNA from being incorporated into a recombinant virus (Roner et al., 2004) . The m1 ssRNA also contains a similar sequence although we have been unable to demonstrate a functional role for the AUU sequence in the m1 ssRNA. Deletion of the sequence does not destroy activity of the m1-CAT ssRNA (data not shown). We are creating new chimeric ssRNAs containing portions of the 5′ regions of both the s2 and m1-CAT ssRNAs to isolate the sequences in the 5′ region that identify the s2 as a reovirus s2 ssRNA and the m1 as an m1 ssRNA.
Work with phi 6 (Mindich, 2004; Pirttimaa and Bamford, 2000; Poranen and Tuma, 2004) has determined that during normal assembly each virus particle contains only one copy of each ssRNA. This "assortment" is possible due to the presence of packaging signals (pac sites) which have been mapped to the 5′ ends of the RNA segments. In addition to the sequences of these pac sites, RNA secondary structure is also important for activity. Based on our findings with the s2 and m1 ssRNAs, we believe a unique sequence/structure also exists in the 5′ regions of the reovirus ssRNAs. Using our data, the 3′ regions of the reovirus ssRNAs are required for the RNAs to be replicated to dsRNA, but this can only occur after the sequences in the 5′ region have been used to identify the ssRNAs as either a reovirus s2 or m1 ssRNA. If we engineer an ssRNA to contain an s2 5′ region, the ssRNA is treated as an s2 ssRNA. Replacing the 5′ region with an m1 sequence results in the ssRNA being replicated and assorted as an m1 ssRNA. The 3′ regions of these ssRNAs are not just "filler" as replacement of these regions with a sequence other than the identified s2 or m1 sequences produces an ssRNA that is "dead" in the reovirus system, never replicated to dsRNA and never incorporated into a virus (data not shown).
We demonstrate in this report that the reovirus system can be used to create a two-CAT gene engineered virus from two in vitro transcribed ssRNAs. The 5′ nucleotide sequence flanking the CAT gene is used to identify the ssRNAs as "s2" or "m1" and leads to the replication of the ssRNAs to dsRNA and incorporation into an infectious reovirus.
Neither the 5′ S2-CAT-M1 3 nor the 5′ M1-CAT-S2 3 ssRNA is able to take the place of both the s2 and m1 ssRNAs and generate a virus with two copies of either of these genes, even when the proteins encoded by both genes are present. This result supports our hypothesis that the reovirus assortment process requires not only 10 ssRNAs, but the signals from 10 ssRNAs. If this were incorrect, we would have expected a virus to be generated that had eight genes with the 5′ S2-CAT-M1 3 or the 5′ M1-CAT-S2 3 as the ninth gene. Alternatively, we could have generated a virus with eight genes and two copies of either the 5′ S2-CAT-M1 3 or the 5′ M1-CAT-S2 35′ M1-CAT-S2 3 as the ninth and tenth genes. When both the 5′ S2-CAT-M1 3 and the 5′ M1-CAT-S2 3 are added to a set of eight ssRNA depleted of the wt s2 and m1 ssRNAs, at least four outcomes were possible. Neither ssRNA could have been incorporated and no virus generated; this did not occur. Two copies of either CAT ssRNA could have been incorporated to generate a virus with 10 genome segments, but two copies of one; this did not occur. One copy of either CAT ssRNA could have been incorporated into a nine-genome segment stable reovirus; this did not occur. Additionally, one copy of each CAT ssRNA could have been incorporated into a 10-genome segmented virus; this is what we isolated. One copy of each ssRNA, the 5′ S2-CAT-M1 3 and 5′ M1-CAT-S2 3 was incorporated into a virus with eight wt genes. Based on our single gene replacement experiments in which the 5′ sequence determines the identity of the ssRNA and subsequent dsRNA, the ssRNA 'S2-CAT-M1 3 was incorporated in place of the wt S2 dsRNA and the ssRNA 5′ M1-CAT-S2 3 as the wt M1 dsRNA. In summary, the reovirus system will allow researchers to engineer any reovirus gene within the limits of required 5′ and 3′ sequence elements. Extension of our work to the L1 and additional genes will add additional data from which a model for reovirus genome packaging and replication will be built.
Materials and methods
Virus and cell lines
Reovirus ST3, strain Dearing (ST3D) and reovirus ST2, strain Jones (ST2J) were used. The recombinant viruses containing the CAT gene were grown in L929 cells transformed with pHβAPr-1-neo (Gunning et al., 1987) that contain the ST3D S2 (L-ST3.S2) (Roner and Roehr, 2006) or the ST3D M1 cDNA (L-ST3.M1) under the control of the human β actin promoter. The L-ST3.M1 cells express protein μ2 that is sufficient to rescue ts H (Ito and Joklik, 1972) , a ST3D virus mutant with a ts mutation in the M1 genome segment. To create a cell line expressing two reovirus proteins, we started with the L-ST3.S2 cell line. This cell line was transfected with the Promega vector pTARGET (#A1410) containing the reovirus ST3D M1 coding sequence cloned into the SmaI site. Cells were selected in the presence of G418 and clones expressing both σ2 and μ2 identified by western blots, SDS-PAGE and the ability of the cell clones to support the replication of both reovirus temperature sensitive mutants ts C and ts H at the nonpermissive temperature of 39.5°C. The cell line was designated L-ST3.S2.M1.
The reovirus reverse genetics system
The system was used as described (Roner et al., 2004; Roner and Joklik, 2001; Roner and Roehr, 2006; Roner et al., 1990) . ST3D capped and methylated mRNA (referred to as ssRNA) was transcribed by cores (Skehel and Joklik, 1969) . After transcription, the cores were pelleted at 10,000×g; the supernatant, which contained the ssRNA was then made 0.5% with respect to sodium dodecyl sulfate (SDS) and extracted three times with phenol/chloroform. The RNA was precipitated with polyethylene glycol (PEG), reextracted three times with phenol/ chloroform and precipitated with 2.5 M ammonium acetate and ethanol. Single-stranded RNA prepared in this manner contained no residual infectious virus. For all lipofections, we used 10 μl of Rabbit Reticulocyte Lysate (Promega #L4960) primed with 0.3-0.5 μg of ST3D ssRNA (this ssRNA is the acceptor set missing either the s2, m1 or both the s2 and m1 ssRNAs and prepared as described in "Removal of wt s2 and m1 ssRNAs to create the accepter ssRNA sets") and 0.1 μg of the indicated s2, m1 or chimeric ssRNA (obtained from in vitro transcription using T7 RNA polymerase and the indicated cDNA template, Promega-RiboMAX™-T7) and 12 units of RNasin Plus RNase Inhibitor (Promega) in a total of 1 μl H 2 O.
Translation was allowed to proceed for 1 h at 30°C. After translation, an additional 0.3-0.5 μg of ST3D ssRNA in 1 μl H 2 O was added and the mixture was immediately added to 0.5 ml of MEM containing penicillin and streptomycin and 50 μl of Lipofectin, or Lipofectamine (Invitrogen Corporation). This mixture was immediately added to PBS-washed monolayers of 10 6 mouse L929 fibroblasts (L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1) in 6-well multiplates. After 6 h, this mixture was replaced with 0.25 ml of MEM containing 4 × 10 7 PFU of ST2J reovirus, and 1 h later 1.75 ml of MEM containing 5% fetal bovine serum was added. After 24 h, the cells were harvested, washed twice in MEM and sonicated in 2 ml of MEM, and virus in the sonicates was titrated on monolayers of the same cell line. To avoid detection of the ST2J helper virus, plaques were counted and selected on day 5, when plaques formed by ST2J virus were not yet detectable.
Removal of wt s2 and m1 ssRNAs to create the accepter ssRNA sets Wild type s2 ssRNA was removed from the mixture of 10 ssRNA species as previously described (Roner et al., 1997) . Briefly, the DNA oligonucleotide selected for this purpose was complementary to nucleotides 937-949; and 10 pmol was added to 2 pmol of s2 ssRNA. After hybridization, the mixture was treated with RNAse H for 20 min. The RNA was extracted three times with phenol/chloroform and precipitated with sodium acetate. Degradation of the s2 ssRNA was confirmed by gel electrophoresis of both the RNA and its translation products.
Similarly, the m1 ssRNA was removed from the mixture of 10 ssRNA species using the DNA oligonucleotide complementary to nucleotides 521-532; 10 pmol were added to 2 pmol of m1 ssRNA. Degradation of the m1 ssRNA was confirmed by gel electrophoresis of both the RNA and its translation products. The set of nine ssRNAs could then be supplemented with the engineered in vitro transcribed m1-CAT ssRNA. To create the acceptor sets missing both the s2 and m1 ssRNAs, the s2 was removed first followed by the m1.
Engineering of reovirus S2 and M1 cDNAs used to generate the engineered ssRNAs As previously described, we can incorporate an engineered reovirus s2 ssRNA into the reovirus genome as a stable dsRNA genome segment (Roner et al., 2004; Roner and Joklik, 2001; Roner and Roehr, 2006) . We used the same procedure to generate the M1-CAT cDNA template. For the M1 cDNA template, 343 nucleotides from the wild type M1 gene precede the CAT gene and 235 nucleotides from the wild type gene follow the CAT gene and generate the 3′ end of the ssRNA. This template is transcribed by T7 RNA polymerase to yield an RNA transcript that possesses 5′ and 3′ terminal sequences as authentic m1 ssRNA. Transcription by T7 RNA polymerase is terminated with the T7 terminator sequence located 3′ of this construct. Transcription of this construction yielded an RNA that contained the 343 5′ nucleotides of m1 RNA fused in frame to the CAT mRNA sequence followed by the 235 3′ terminal nucleotides of m1 RNA. This was achieved by inserting the HDV ribozyme sequence in such a way that when the ribozyme underwent autocleavage, it left a terminal C at the 3′ terminus. As a result, the 3′ terminal sequence of the transcript was the authentic reovirus RNA 3′ terminal sequence-UCAUC. Recloning and subsequent sequencing and cleavage analysis confirmed the authenticity of the 5′ and 3′ terminal sequences. This cDNA template, pM1CAT1330, is summarized in a diagram in Fig. 1 .
The pM1CAT1330 construct was transcribed in vitro using T7 RNA polymerase and the transcript was capped using m 7 GpppG (Promega) to yield s2-CAT mRNA. It was translated in vitro using a rabbit reticulocyte lysate system (Promega) and the lysate was found to contain CAT activity (CAT-ELISA, Boehringer Mannheim Corporation). This ssRNA was used to supplement the acceptor ssRNA sets and lipofected into cells to generate virus.
Mutagenesis of 5′ and 3′ m1 sequences flanking the CAT gene in construct pM1CAT1330
Sequential deletion and mutagenesis of the 5′ and 3′ M1-CAT flanking sequences was carried out using GeneEditor by Promega (#Q9280). This system uses antibiotic selection to obtain a high frequency of mutants. Selection oligonucleotides provided with the GeneEditor System encode mutations that alter the ampicillin resistance gene, creating a new additional resistance to the GeneEditor Antibiotic Selection Mix. As directed by the manufacturer, we annealed the selection oligonucleotide to our pM1CAT1330 double-stranded DNA template at the same time as a mutagenic oligonucleotide. Subsequent synthesis and ligation of the mutant strand link the two oligonucleotides. The mutagenic oligonucleotides we selected were all 50 or more nucleotides in length, 25 nucleotides matching the M1 and/or CAT nucleotide sequence depending upon the location of the sequence we wished to retain and 25 nucleotides matching the HDV-ribozyme nucleotide sequence. Using 25 perfectly matched nucleotides on each side of the mismatched sequence we wished to loop-out and remove, we were able to remove nucleotides from the original pM1CAT1330 sequence. We initially made large 50 base deletions and narrowed down sequence using single nucleotide deletions. The results are summarized in Table 1 and Fig. 2 .
Construction of chimeric cDNA templates
As outlined in Fig. 3 , part C, the 5′ S2-CAT-S2 3′ cDNA is identical to the pS2CAT3 m template (Roner and Roehr, 2006) and the 5′ M1-CAT-M1 3′ cDNA is identical to the pM1CAT1048 template described in this paper. Mutagenesis of these templates to yield the chimeric cDNAs 5′ S2-CAT-M1 3′ and 5′ M1-CAT-S2 3′ was carried by swapping restriction fragments. Briefly, the 5′ fragment from the multiple cloning site (MCS, HindIII) to an internal EcoR1 within the CAT gene (#247) was excised from both pS2CAT3 m and pM1CAT1048 and exchanged with each other to yield 5′ M1-CAT-S2 3′ and 5′ S2-CAT-M1 3′ . A partial EcoR1 digest was required as an additional EcoR1 site exists at the 3′ end of the cDNAs, a remnant of the original MCS. The final length of the ssRNAs transcribed from these cDNAs is summarized in Fig. 3 , part C.
Virus titration/determination of CAT activity
Monolayers of lipofected and infected L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1 cells were incubated at 37°C for 5 days. Neutral red was added 24 h before counting plaques (Roner et al., 2004; Roner and Joklik, 2001; Roner and Roehr, 2006) . CAT activity in cell lysates was assayed using CAT ELISA (Boehringer Mannheim Corporation). We measure the CAT activity of our engineered viruses as a method to screen large numbers of recombinant viruses when we encounter ssRNAs that are inefficiently incorporated in progeny viruses. Although useful this activity is not used to confirm that we have generated a recombinant virus. The CAT activity is low as it is expressed as a σ2-CAT or μ2 fusion protein. The engineered dsRNAs of all recombinant viruses were sequenced to confirm the presence of the indicated genome segment and its exact nucleotide sequence.
Detection of reovirus s2 and m1 ssRNAs in vivo
Twelve hours following lipofection of L929 or L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1 cells with the indicated ssRNAs, protein translation mixture and infection with reovirus serotype 2 helper virus, total RNA was extracted from the cell monolayers using Eppendorfs' Perfect RNA Eukaryotic Mini kit and protocols. The ssRNA was electrophoresed in a formaldehyde denaturing gel using Ambion, Inc.'s NorthernMax kit. Following the manufacturer's protocol, the ssRNA was transferred to a BrightStar-Plus Positively Charged Nylon Membrane and UV-cross linked. Hybridization/detection was carried out at 40°C according to manufacturer's directions using UltrahybTM buffer and 32 P-labeled oligonucleotides. For detecting the ST3D s2 ssRNA, the oligonucleotide (S2.5) 5′ CAAACCACCAGACGTTTTACACGGTTAATTGCTGCTT-GATA3′ complementary to nucleotides 55 to 95 near the 5′ end of the s2 RNA was used. The oligonucleotide S2.5 was selected because it is 19.5% mismatched with the ST2J s2 sequence and, when used as an ssRNA probe, does not detect the ST2J s2 ssRNA or the S2 dsRNA genome segment. For detecting the ST3D m1 ssRNA, the oligonucleotide (M1.5) 5′ GAACGACATTCGCGTCAGCCCCAGCGTCTACTC-CAAACG3′ complementary to nucleotides 120 to 81 near the 5′ end of the m1 RNA was used. The oligonucleotide M1.5 was selected because it is 42% mismatched with the ST2J m1 sequence and, when used as an ssRNA probe, does not detect the ST2J m1 ssRNA or the M1 dsRNA genome segment. For detecting the s2/CAT or m1/CAT ssRNA, the oligonucleotide (CAT.1) 5′TTTACGATGCCATTGGGATATATCGGTGGTA-TATCC3′ complementary to CAT gene was used. The membrane was used to expose X-ray film.
Detection of reovirus CAT/S2 and CAT/M1 dsRNA in vivo
Twelve hours following lipofection of L929 or L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1 cells with the indicated ssRNAs, protein translation mixture and infection with reovirus serotype 2 helper virus, total cell monolayers were harvested. The dsRNA was electrophoresed in 7.5% SDS-PAGE gels for 2650 volt/h as described (Moody and Joklik, 1989) . Following the protocol used for the ssRNA gels, the dsRNA was transferred to a BrightStar-Plus Positively Charged Nylon Membrane and UV-cross linked. Hybridization/detection was carried out at 40°C according to manufacturer's directions, using UltrahybTM buffer and 32 P-labeled oligonucleotides. For detecting the s2/CAT or m1/CAT ssRNA, the oligonucleotide CAT.1 (Roner et al., 2004) complementary to CAT gene was used. The membrane was used to expose X-ray film.
Recombinant virus purification
Forty-eight hours following lipofection of L929 or L-ST3. S2, L-ST3.M1 or L-ST3.S2.M1 cells with the indicated ssRNAs, protein translation mixture and infection with reovirus serotype 2 helper virus, total cell monolayers were harvested. Serial 10-fold dilutions were prepared from these lysates and monolayers of L929 or L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1 cells were infected. After incubation at 37°C for 5 days, neutral red was added 24 h before counting plaques (Roner et al., 2004; Roner and Joklik, 2001) . Visualized plaques were selected using Pasteur pipettes and placed in 1 ml MEM without serum. This plaque-purification process was repeated three times. The dsRNA genomes of each three-time plaque-purified isolate were then analyzed by SDS-PAGE. In summary, individual wells of 96 well plates of L929 or L-ST3.S2, L-ST3.M1 or L-ST3.S2.M1 cells were infected with 50 μl of each isolate. After incubation at 37°C for 24 h, 1 μCi 32 P orthophosphate was added to each well. After an additional 24 h, 50 μl 2× Laemmli sample buffer was added to each well and the plates stored at − 20°C. The plates were heated to 65°C for 10 min and 10 μl of each well loaded onto a 7.5% SDS-PAGE gel and electrophoresis carried out for 2650 volt/h. The gels were immediately dried and used to expose X-ray film. For recombinant viruses that should have the CAT gene expressed in frame, CAT activity was checked as an additional screen, and all recombinant reoviruses were identified by sequencing of the engineered dsRNAs to confirm that the engineered ssRNA made in vitro had been incorporated as constructed.
Sequencing of cDNA templates and recombinant viruses
All cDNA templates were sequenced to confirm the presence of the desired mutations. The T7-generated ssRNAs were sequenced using two methods: the 5′ 200 nucleotides sequenced using reverse transcriptase (RT) and a complementary primer, the 3′ ends first poly-A tailed using yeast poly-A polymerase, then sequenced using RT and an oligo-T primer, as described (Roner et al., 2004; Roner and Joklik, 2001; Wiener et al., 1989) . Following purification, all recombinant reoviruses were propagated and the engineered dsRNA genome segments sequenced directly using reverse transcriptase as described (Wiener et al., 1989) .
